SBC Medical Group Holdings Incorporated
NASDAQ:SBCConsulting Services
+$0.04 today
- Market cap
- $644.85M
- Beta
- 0.59
- P/E (TTM)
- 7.6
- EPS (TTM)
- $0.40
Volume 0.56M
Average 0.12M
SBC Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
SBC Medical Group Holdings IncorporatedNASDAQ: SBC
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash declines year over year
Q1 FY2026 net change in cash of $3.53M fell 49.6% year over year, behind the -1.7% change in trailing-twelve-month net change in cash. Sequentially, it fell 90.3% from the prior quarter.
Context
- Net change in cash amounted to 22.3% of revenue in FY2025, up 11.6 pp from a year earlier.
- Net change in cash increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -49.6% toward the trailing-twelve-month pace of -1.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 38.73M USD
- Year-over-year change
- +75.9%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 38.73M | +75.9% |
| FY2024 | 2024-12-31 | 22.02M | -57.1% |
| FY2023 | 2023-12-31 | 51.28M | +197.2% |
| FY2022 | 2022-12-31 | (52.77M) | — |
Net Change in Cash vs competitors
How SBC compares with its peers on the latest reported figures
- SBC's LTM Mar 2026 net change in cash of $35.25M is the largest of the 3 companies compared; the peer median is $15.37M.
- Its year-over-year change of -1.7% is the 2nd highest of 3, against a peer median of +7.6%.
- Net change in cash amounts to 20.8% of revenue for SBC, versus a peer median of 14.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $35.25M | -1.7% | — | 20.8% |
| LTM Mar 2026 | $28.58M | -214.9% | +197.9% | 9.2% | |
RYOJrYojbaba Co., Ltd. Common Shares | FY2024 | $2.17M | +230.1% | — | 18.7% |
| Peer median (excluding SBC) | $15.37M | +7.6% | +197.9% | 14.0% | |
Competitors are the stored peer set for SBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | 5.55M | 39.37M | 46.61M | 50.99M |
| Depreciation & Amortization | 5.93M | 12.25M | 3.8M | 2.68M |
| Deferred Income Tax | (3.9M) | 4.11M | (14.42M) | 5.33M |
| Stock-Based Compensation | 0 | 0 | 13.02M | 0 |
| Change in Working Capital | (10.59M) | (7.68M) | (12.13M) | (12.28M) |
| Accounts Receivables | (9.6M) | (6.01M) | 13.1M | 4.47M |
| Inventory | (666.64K) | (1.83M) | 1.12M | (170.17K) |
| Accounts Payables | 172.61K | 12.2M | (8.91M) | 2.67M |
| Other Working Capital | (493.08K) | (12.04M) | (17.45M) | (19.24M) |
| Other Non-Cash Items | 2.96M | 2.59M | (16.31M) | (7.79M) |
| Operating Cash Flow | (47.37K) | 50.64M | 20.58M | 38.92M |
| Capital Expenditures | (24.95M) | (11.21M) | (3.41M) | (2.37M) |
| Acquisitions (Net) | (6.49M) | 722.55K | (5.07M) | (15.46M) |
| Purchases of Investments | (2.65M) | (2.11M) | (331.5K) | (21.05M) |
| Sales of Investments | 0 | 4.13M | 0 | 0 |
| Other Investing Activities | 1.43M | 8.6M | (1.29M) | 18.34M |
| Investing Cash Flow | (32.65M) | 1.82M | (10.1M) | (20.97M) |
| Debt Repayment | (5.08M) | 3.58M | 6.48M | 18.83M |
| Common Stock Issued | 118.82M | 10 | 31.37K | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (5M) |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | (121.72M) | 2.56M | 16.45M | 10.21M |
| Financing Cash Flow | (7.98M) | 6.14M | 22.97M | 24.04M |
| Effect of Forex Changes | (12.09M) | (7.31M) | (11.42M) | (3.26M) |
| Net Change in Cash | (52.77M) | 51.28M | 22.02M | 38.73M |
| Free Cash Flow | (24.99M) | 39.44M | 17.17M | 36.55M |
SBC Medical Group Holdings Incorporated
NASDAQ:SBC
Intrinsic Alpha fair value
Locked
Current Price
$6.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.